Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hee-Seung Kim

Showing results (191-200 of 306) with videos related to

Pageof 31
Sort By:
Journal of Gynecologic Oncology|March 23, 2022
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trialJung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, et al.
Cancer Research and Treatment|March 13, 2015
Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort StudyHee Seung Kim, Hwa-Young Choi, Maria Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Prognosis of adenosquamous carcinoma compared with adenocarcinoma in uterine cervical cancer: a systematic review and meta-analysis of observational studiesJung-Yun Lee, Chulmin Lee, Seokyung Hahn, et al.
Annals of Surgical Oncology|February 15, 2015
Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysisHee Seung Kim, Min A Kim, Maria Lee, et al.
Journal of Gynecologic Oncology|March 30, 2026
Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)Kyung Hee Han, Eunjung Yang, Namkyeong Kim, et al.
Gynecologic Oncology|December 14, 2017
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencingSe Ik Kim, Ji Won Lee, Maria Lee, et al.
BMC Cancer|September 9, 2022
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinomaSe Ik Kim, Hyung-Chul Lee, Hyun-Kyu Yoon, et al.
Gynecologic Oncology|December 31, 2021
Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approachSe Ik Kim, Bo Ram Choi, Hee Seung Kim, et al.
BMC Cancer|January 4, 2022
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancerSoo Jin Park, Suk-Joon Chang, Dong Hoon Suh, et al.
Journal of Immunology Research|July 23, 2014
Impact of underweight after treatment on prognosis of advanced-stage ovarian cancerSe Ik Kim, Hee Seung Kim, Tae Hun Kim, et al.
Pageof 31

Showing results (191-200 of 306) with videos related to

Sort By:
Pageof 31
Journal of Gynecologic Oncology|March 23, 2022
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trialJung-Yun Lee, Byoung-Gie Kim, Jae-Weon Kim, et al.
Cancer Research and Treatment|March 13, 2015
Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort StudyHee Seung Kim, Hwa-Young Choi, Maria Lee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Prognosis of adenosquamous carcinoma compared with adenocarcinoma in uterine cervical cancer: a systematic review and meta-analysis of observational studiesJung-Yun Lee, Chulmin Lee, Seokyung Hahn, et al.
Annals of Surgical Oncology|February 15, 2015
Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysisHee Seung Kim, Min A Kim, Maria Lee, et al.
Journal of Gynecologic Oncology|March 30, 2026
Primary chemoradiation versus radical hysterectomy with lymphadenectomy for stage IIICr cervical cancer without parametrial involvement: gynecologic oncology research investigators collaboration study (GORILLA-1002)Kyung Hee Han, Eunjung Yang, Namkyeong Kim, et al.
Gynecologic Oncology|December 14, 2017
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencingSe Ik Kim, Ji Won Lee, Maria Lee, et al.
BMC Cancer|September 9, 2022
Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinomaSe Ik Kim, Hyung-Chul Lee, Hyun-Kyu Yoon, et al.
Gynecologic Oncology|December 31, 2021
Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approachSe Ik Kim, Bo Ram Choi, Hee Seung Kim, et al.
BMC Cancer|January 4, 2022
A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancerSoo Jin Park, Suk-Joon Chang, Dong Hoon Suh, et al.
Journal of Immunology Research|July 23, 2014
Impact of underweight after treatment on prognosis of advanced-stage ovarian cancerSe Ik Kim, Hee Seung Kim, Tae Hun Kim, et al.
Pageof 31